Quality Improvement

Clinics in the T1D Exchange Quality Improvement Collaborative (T1DX-QI) network develop and disseminate best practices in T1D care. The T1DX-QI currently brings together 55 endocrinology clinics across the United States treating over 85,000 people with type 1 diabetes — and 20,000+ with type 2 diabetes through a new pilot program.

New clinics across the United States are joining every year — is your clinic next?

Since its creation, the T1DX-QI has accomplished a variety of impactful work, including:

• 90+ active research projects striving to improve patient care
• Launched a pilot program to serve the type 2 diabetes population
• Published research in over 40 top medical journals since 2019
• Shared 70+ presentations at international conferences
• Influencing active international collaborations
• Expanding the Health Equity Advancement Lab (HEAL) Program
• Mapping data at 16 participating centers
• Improving overall HbA1c trends across all participating clinics
• 18 manuscripts accepted and published so far in 2022
• 25 abstracts accepted/presented at 5 International conferences in 2022

Regarding real-world results, the T1DX-QI has seen significant success in improving patient care across member clinics, including:

• Increasing CGM prescriptions and use
• Developing programs to help patients with A1c’s over 9%
• Increasing access to diabetes technology in certain racial/ethnic groups
• Improving mental health screen in both adult and pediatric clinics
• Increasing clinic visit frequency in Medicaid-insured youth
• Decreasing DKA hospitalizations through a targeted diabetes wellness program
• Increasing follow-up attendance after DKA hospitalizations
• Creating screening to identify and address fear of hypoglycemia
• …and more!